Document is current
Any future updates will be listed below
-
Authors
Huo, Xingyu
Chen, Juntong
Qian, Maojiao
Xue, Qian
Xu, Pengzhan
Wang, Yueming
Jiang, Zhonglin
Luo, Qianqian
Xiong, Yanlian https://orcid.org/0000-0001-5178-8932
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32200731)
- License Information
-
More Information
Article History
Received: 3 April 2025
Accepted: 19 August 2025
First Online: 27 August 2025
Declarations
:
: This study was approved by the Ethics Committee of Binzhou Medical University: Project title: Study on the mechanism of stem cell exosomes in treating endometrial fibrosis. Approval number: No. 2024-26. Date of approval: June 25, 2024. We obtained the human umbilical cord from Affiliated Yantai Hospital of Binzhou Medical University. The participants provided written informed consent for the use of the samples (hUMSCs). The isolation and using of hUMSCs have been approved by the Ethics Committee of Affiliated Yantai Hospital of Binzhou Medical University (Approval number: 2022 − 123, Date of approval: October 16, 2022). The hESCs source company Wuhan Churuike Pharmaceutical Technology Co., Ltd. (CRK Pharma, China) obtained prior ethical approval to collect human cells and all donors signed informed consent forms.
: Not applicable.
: The authors declare that they have no conflict of interests.
